Bio-Techne Corporation (TECH) stock analysis

In our weekly check, Bio-Techne Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 7, red flags: 2.

About Bio-Techne Corporation

Bio-Techne Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TECH.

What our checks show for TECH

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-02

Similar companies

HALO · SMMT · BMRN · KYMR · PCVX · MDGL

Questions

What grade does Bio-Techne Corporation (TECH) have?

In our weekly check, Bio-Techne Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 16 pass, warnings: 7, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of TECH stock?

This week's biggest flags for Bio-Techne Corporation: Margins falling, Deep past fall, Gross margin falling. In total 9 of 25 checks show a warning or a red flag.

What does Bio-Techne Corporation do?

Bio-Techne Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as TECH.

When does Bio-Techne Corporation report earnings next?

The next earnings report is expected on 2027-02-02. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis